[REGN] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 4.07%
YoY- -23.40%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 3,547,100 3,145,000 3,434,300 3,362,700 3,158,100 3,162,100 3,414,400 2.57%
PBT 1,628,100 700,700 1,147,600 1,110,800 1,082,900 858,000 1,324,700 14.75%
Tax 195,800 -21,300 -12,000 103,000 114,500 40,200 127,600 33.07%
NP 1,432,300 722,000 1,159,600 1,007,800 968,400 817,800 1,197,100 12.71%
Tax Rate -12.03% 3.04% 1.05% -9.27% -10.57% -4.69% -9.63% -
Total Cost 2,114,800 2,423,000 2,274,700 2,354,900 2,189,700 2,344,300 2,217,300 -3.10%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 40.38 22.96 33.77 29.97 30.66 25.86 35.06 9.88%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 13.25 6.70 10.88 9.48 9.05 7.64 11.19 11.93%
EPS Diluted 12.41 6.27 10.19 8.89 8.50 7.17 10.50 11.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.